Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

849 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A new perspective on transcriptional system regulation (TSR): towards TSR profiling.
Fehrmann RS, de Jonge HJ, Ter Elst A, de Vries A, Crijns AG, Weidenaar AC, Gerbens F, de Jong S, van der Zee AG, de Vries EG, Kamps WA, Hofstra RM, Te Meerman GJ, de Bont ES. Fehrmann RS, et al. Among authors: de jonge hj, de vries a, de vries eg, de bont es, de jong s. PLoS One. 2008 Feb 20;3(2):e1656. doi: 10.1371/journal.pone.0001656. PLoS One. 2008. PMID: 18297136 Free PMC article.
Topoisomerases, new targets in cancer chemotherapy.
Zijlstra JG, de Jong S, de Vries EG, Mulder NH. Zijlstra JG, et al. Among authors: de vries eg, de jong s. Med Oncol Tumor Pharmacother. 1990;7(1):11-8. doi: 10.1007/BF03000485. Med Oncol Tumor Pharmacother. 1990. PMID: 2160032 Review.
Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
de Jong S, Kooistra AJ, de Vries EG, Mulder NH, Zijlstra JG. de Jong S, et al. Among authors: de vries eg. Cancer Res. 1993 Mar 1;53(5):1064-71. Cancer Res. 1993. PMID: 8382551
GLC4/ADR cells demonstrated a reduced Topo II activity and no detectable levels of the P-glycoprotein compared to the parental GLC4 cells (S. De Jong et al., Cancer Res., 50: 304-309, 1990). In the present study, the resistance to VM-26 (59.5-fold) and to m-A …
GLC4/ADR cells demonstrated a reduced Topo II activity and no detectable levels of the P-glycoprotein compared to the parental GLC4 cells ( …
849 results